This notion is further confirmed by our recent study showing that the effects of the anti-inflammatory endogenous molecule, Ang-(1-7), in asthma, are mediated via inhibition of the EGFR/ERK1/2 dependent signaling (El-Hashim et al., 2019). Here, MAPK3 is linked to asthma.